Private Client Services’s Bristol-Myers Squibb BMY Stock Holding History

Private Client Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,519	Closed	-$286K	–	190
2024 Q3	$286K	Sell	5,519 -1,885	-25%	-$88.4K	0.15%	124
2024 Q2	$307K	Buy	7,404 +1,791	+32%	+$80.1K	0.19%	98
2024 Q1	$304K	Sell	5,613 -251	-4%	-$12.8K	0.2%	96
2023 Q4	$301K	Buy	+5,864	New	+$308K	0.25%	103

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Private Client Services's BMY Position: Q4 2024 in Review

Private Client Services sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 5,519 shares — an estimated $286K sold.

Private Client Services first reported a position in BMY in Q4 2023 and held it in 4 quarters. The position peaked at $307K in Q2 2024. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Private Client Services reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Private Client Services sold 5,519 Bristol-Myers Squibb shares in Q4 2024, an estimated $286K.
Private Client Services first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 4 quarters.
Private Client Services's Bristol-Myers Squibb position peaked at $307K in Q2 2024.
2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Private Client Services's 13F filing for Q4 2024, filed 8 Jan 2025.